Authors
Latest:
Treatment of VUR: The bar is raised, morbidity loweredThe treatment paradigm for vesicoureteral reflux has undergone a significant shift in recent years. Endoscopic surgery has provided an effective, minimally invasive option that is gradually eliminating the need for prolonged antibiotic use, monitoring with voiding cystourethrograms (VCUGs), and open surgery in children with most grades and forms of VUR.
Latest:
Active Surveillance in Muscle Invasive Bladder CancerTypes of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.
Latest:
Prostate biopsies: How well do they predict tumor location?Although needle biopsies are being used for localization, the majority of prostate cancers are multifocal in nature and invisible on gray scale ultrasonography.
Latest:
How to restart your practice when the COVID-19 red light turns green"In the current environment of coronavirus disease 2019 (COVID-19), it has become obvious that it won’t be business as usual when the economy restarts and social distancing restrictions are relaxed," write Steven A. Kaplan, MD, and Alexis E. Te, MD.
Latest:
Endoscopic robotic platforms: What the future holdsThis article highlights some of the emerging endoscopic robotic systems in urology.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Good and bad news: ED patients often don't returnQuebec City, Quebec--The good news is that most patients being treated for erectile dysfunction report that their treatment is working. The bad news is that a significant percentage of these same patients are often lost to follow-up for that very reason, according to a study by urologists from McGill University.
Latest:
CP/CPPS therapies may yield long-sought answersResearch has begun to examine a range of novel treatment modalities, some with quite promising results.
Latest:
Nocturia: Data point to multiple etiologiesRecent studies suggest that nocturia has many etiologies, including urologic, metabolic, and perhaps most important, behavorial.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
The physician executive: How one urologist balances MD, CEO rolesIn this interview, physician executive J. Christian Winters, MD, outlines his multiple professional roles, explains how he divides his time between clinical and administrative responsibilities, and offers advice to young urologists seeking a career in leadership.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
The promise of PD-1 ligand pathway in treating bladder cancerResearchers have recently made progress in understanding a fundamental signaling cascade, the Programmed Death 1 (PD-1) receptor-ligand pathway,1 which holds long-awaited promise in bladder cancer intervention.
Latest:
Transgender surgery: Videos demonstrate cutting-edge techniquesIn these videos, expert surgeons demonstrate robot-assisted penile inversion vaginoplasty, single-stage metoidioplasty, and simple orchiectomy for transgender patients.
Latest:
Botulinum formulations show slight outcomes differencesA new comparative study showed that the use of intradetrusor injections of abobotulinum toxin A (Dysport) for urinary incontinence due to neurogenic detrusor overactivity provided results that were similar to or superior to those seen with onabotulinum toxin A (Botox), depending on the dosage of the latter.
Latest:
Adjuvant therapy fails in locally advanced kidney CaTwo angiogenesis inhibitors that are widely used in metastatic renal cell carcinoma did not improve survival compared with placebo when used as adjuvant treatment, a new study found.
Latest:
What Part B data reveal about BPH procedure usage"As investigational therapies and devices make their way through the approval process and into practice, urologists should stay abreast of early clinical results and may look to publicly available information for costs and utilization trends," writes Robert A. Dowling, MD.
Latest:
Expert pointers on BPH evaluation and treatmentIn this interview, Alexis E. Te, MD, discusses the evolution of LUTS treatment, what primary care providers should include in their evaluation when seeing a patient with LUTS, and how he selects treatments for patients with BPH.
Latest:
Research on bladder tissue regeneration progressesAtlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.
Latest:
HIFU may offer advantages in PCa, but the jury is still outOver the last 20 years, radical retropubic prostatectomy has evolvedto become the standard of care in men with localized prostate cancer. Becauseof the morbidity of this procedure, however, interest has grown in the developmentof non-surgical modalities. Unfortunately, many of these non-surgical approaches,such as monotherapy with radioactive seed implantation, have resulted indisappointing results or excessive morbidity, as in first-generation cryotherapy.
Latest:
Wrong testicle removed during surgery"At trial, the urology expert testified that the defendant urologist failed to offer the patient alternative treatments before proceeding with the drastic option of removing the testicle," writes Dawn Collins, JD.
Latest:
Low-dose CT stone detection: Safe during pregnancyTreatment for pregnant women who present with renal or ureteral colic may have become easier for physician and patient alike.
Latest:
Survey data show positive signs for urology's futureThe most recent Urology Times State of the Specialty survey is notable in confirming some widely accepted urologic practice trends, but challenging the significance of others.
Latest:
Dr. Wolf on the CVAC System for steerable ureteroscopic renal evacuation“I cannot overstate the impact of this device on my management of kidney stone patients," says J. Stuart Wolf, Jr., MD, FACS.
Latest:
How to administer anesthesia in the urology officeThe procedure should be of a durationand complexity that will permit the patient to recover and be discharged.
Latest:
Evolution of ureteral stents: Work is still neededSeveral approaches have been taken to attenuate lower urinary tract symptoms and improve quality of life in the stented patient.
Latest:
How to perform metabolic evaluation in stone formersPatients with nephrolithiasis frequently have metabolic abnormalities that promote calculus formation and, when identified and corrected, may attenuate stone activity.
Latest:
Newer PNL methods improve safety, reduce morbidityMontreal--Novel approaches to percutaneous nephrolithotomy, includinguse of a stent instead of a tube and using smaller tubes and stone "cones,"are helping to optimize this procedure. Researchers agree that improvingsafety and reducing morbidity are the goals of these new techniques.
Latest:
Your high-maintenance urology office staffer: Worth the hassle?Every urology practice faces this situation eventually: a difficult employee who demands disproportionate time and attention from management.
